Double maintains 2 strategies that include COLL - Collegium Pharmaceutical, Inc.
Yahoo
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
Yahoo
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Collegium Pharmaceutical (NASDAQ:COLL) and the rest of the branded pharmaceuticals stocks fared in Q4.
Yahoo
STOUGHTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that management will participate in a fireside chat at the 24th Annual Needham Healthcare Conference being held virtually from April 7-10, 2025. Details of the event are as follows:Fireside Chat Date and Time: Tuesday, April 8, 2025, at 9:30 a.m. ET The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpha
Yahoo
STOUGHTON, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present four posters highlighting real-world patient data from its differentiated pain portfolio at PainConnect 2025, the American Academy of Pain Medicine (AAPM)’s Annual Meeting, being held in Austin, TX, from April 3-6, 2025. Among these, the poster titled “Route of Administration and Other Clinical Outcomes Among Exposures to Buprenorphine Pain Medications and Schedule I
Yahoo
WAYNE, Pa. and ROCKVILLE, Md., March 26, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, today announced the appointment of Michael Heffernan as Chairman of the Board of Directors (“Board”). Mr. Heffernan will succeed Dr. Garry Neil as Chairman of the Board. Dr. Neil will continue as a Board member and Chief Executive Officer (CEO) of the Company. “We are thrilled to welcome Michael to Avalo’s Bo
Yahoo
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Royalty Pharma (NASDAQ:RPRX) and the rest of the branded pharmaceuticals stocks fared in Q4.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MGNX | 38.11% | $76.97M | -91.08% | 0.00% |
YELP | 37.23% | $2.50B | -6.25% | 0.00% |
SANA | 36.79% | $366.79M | -82.21% | 0.00% |
ACCD | 36.70% | $573.13M | -25.32% | 0.00% |
AMN | 33.50% | $891.99M | -59.96% | 0.00% |
AKAM | 32.45% | $12.28B | -23.77% | 0.00% |
EVH | 32.45% | $1.17B | -66.58% | 0.00% |
LAW | 32.22% | $253.01M | -47.23% | 0.00% |
APAM | 32.15% | $2.82B | -10.08% | 8.12% |
VIR | 31.10% | $888.69M | -33.13% | 0.00% |
DNOW | 30.96% | $1.83B | +14.94% | 0.00% |
WLY | 30.94% | $2.45B | +18.37% | 3.22% |
SCL | 30.77% | $1.23B | -38.12% | 3.04% |
SLF | 30.70% | $33.67B | +10.14% | 4.06% |
KFRC | 29.67% | $952.88M | -26.09% | 3.24% |
BBSI | 29.66% | $1.07B | +32.61% | 1.34% |
NVEE | 29.63% | $1.30B | -16.85% | 0.00% |
VCTR | 29.59% | $3.87B | +42.38% | 3.05% |
PATK | 29.47% | $2.97B | +13.68% | 2.58% |
LGIH | 29.45% | $1.57B | -37.22% | 0.00% |
Current Value
$29.551 Year Return
Current Value
$29.551 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
POAI | 0.01% | $10.09M | -28.57% | 0.00% |
NIU | -0.03% | $287.71M | +153.05% | 0.00% |
EXK | -0.03% | $983.72M | +34.41% | 0.00% |
NFLX | 0.06% | $400.18B | +48.48% | 0.00% |
FVRR | -0.09% | $879.42M | +17.80% | 0.00% |
UPST | -0.11% | $4.46B | +81.17% | 0.00% |
XGN | -0.14% | $79.29M | +185.81% | 0.00% |
LNTH | 0.15% | $6.67B | +64.59% | 0.00% |
SEI | -0.15% | $870.14M | +160.11% | 2.48% |
ADC | 0.15% | $8.21B | +35.86% | 3.89% |
MFIC | 0.15% | - | - | 12.17% |
RILY | 0.17% | $118.63M | -83.06% | 13.83% |
FRO | -0.17% | $3.33B | -38.83% | 12.30% |
MTLS | 0.18% | $281.75M | -8.09% | 0.00% |
PWR | 0.18% | $39.21B | +0.88% | 0.15% |
CDNS | 0.19% | $72.68B | -14.70% | 0.00% |
RLX | 0.21% | $1.80B | +2.19% | 0.55% |
AQB | -0.24% | $2.67M | -65.15% | 0.00% |
BEEM | 0.25% | $30.58M | -68.25% | 0.00% |
LQDA | 0.30% | $1.24B | -5.41% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CGSM | -16.87% | $640.07M | 0.25% |
BSMR | -16.59% | $235.44M | 0.18% |
IBMS | -16.20% | $46.94M | 0.18% |
BSMW | -15.10% | $101.29M | 0.18% |
FLMI | -14.92% | $613.41M | 0.3% |
JMST | -14.89% | $3.54B | 0.18% |
CORN | -14.56% | $52.17M | 0.2% |
SUB | -14.39% | $8.76B | 0.07% |
PZA | -13.90% | $3.00B | 0.28% |
TAXF | -13.90% | $517.32M | 0.29% |
FMB | -13.24% | $2.00B | 0.65% |
TFI | -13.06% | $3.29B | 0.23% |
MLN | -12.88% | $534.56M | 0.24% |
MMIN | -12.75% | $473.48M | 0.3% |
TAIL | -12.53% | $87.65M | 0.59% |
VIXY | -12.50% | $195.31M | 0.85% |
HYD | -12.20% | $3.45B | 0.32% |
SGOV | -12.13% | $39.98B | 0.09% |
WEAT | -11.79% | $115.75M | 0.28% |
VTEB | -11.59% | $36.03B | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NVAX | -30.30% | $961.85M | +31.72% | 0.00% |
K | -13.05% | $28.46B | +45.70% | 2.75% |
ADMA | -12.45% | $4.81B | +218.58% | 0.00% |
GEN | -12.35% | $16.65B | +22.44% | 1.92% |
LITB | -11.25% | $41.93M | -46.48% | 0.00% |
UI | -11.10% | $19.65B | +199.03% | 0.83% |
STG | -10.47% | $28.76M | -44.31% | 0.00% |
EDN | -10.06% | $669.95M | +61.34% | 0.00% |
IONQ | -10.01% | $5.58B | +168.78% | 0.00% |
HIMX | -9.94% | $1.31B | +38.45% | 4.37% |
MNOV | -9.74% | $69.16M | -7.24% | 0.00% |
ITOS | -9.57% | $220.38M | -56.02% | 0.00% |
QXO | -9.50% | $6.03B | -83.01% | 0.00% |
DAO | -9.18% | $250.16M | +95.84% | 0.00% |
LPTH | -8.62% | $80.72M | +38.62% | 0.00% |
API | -8.43% | $294.31M | +55.60% | 0.00% |
BBDO | -8.39% | $10.83B | -15.18% | 3.50% |
BNED | -8.38% | $364.72M | -83.00% | 0.00% |
CDNA | -8.28% | $1.02B | +83.17% | 0.00% |
PG | -8.21% | $397.45B | +8.55% | 2.32% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTM | -0.03% | $310.98M | 0.07% |
UBND | 0.04% | $627.77M | 0.4% |
VMBS | -0.08% | $19.36B | 0.03% |
CPNJ | -0.08% | $29.63M | 0.69% |
TLTW | 0.11% | $1.16B | 0.35% |
IAGG | -0.11% | $6.72B | 0.07% |
JCPB | 0.13% | $6.09B | 0.38% |
USCI | -0.13% | $240.82M | 1.07% |
BOND | 0.14% | $5.54B | 0.7% |
WIP | -0.15% | $317.54M | 0.5% |
NUAG | 0.16% | $56.52M | 0.21% |
CARY | 0.17% | $347.36M | 0.8% |
JPLD | -0.19% | $1.15B | 0.24% |
GNMA | -0.22% | $355.69M | 0.1% |
TIPX | 0.22% | $1.68B | 0.15% |
HDRO | 0.23% | $164.26M | 0.3% |
FIXD | 0.24% | $4.00B | 0.65% |
STXT | -0.24% | $134.22M | 0.49% |
AGG | 0.25% | $124.99B | 0.03% |
BUXX | -0.28% | $234.79M | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 40.33% | $48.38M | 0.69% |
CALF | 38.00% | $5.14B | 0.59% |
XPH | 36.86% | $158.14M | 0.35% |
PBE | 36.45% | $224.98M | 0.58% |
RSPA | 34.58% | $292.67M | 0% |
SYLD | 32.11% | $1.04B | 0.59% |
XSLV | 32.06% | $281.41M | 0.25% |
XSVM | 32.01% | $627.16M | 0.37% |
RZV | 31.85% | $200.40M | 0.35% |
QVAL | 31.54% | $361.32M | 0.29% |
SMMV | 31.39% | $284.96M | 0.2% |
RWJ | 31.23% | $1.59B | 0.39% |
EES | 31.22% | $575.29M | 0.38% |
DES | 31.00% | $1.86B | 0.38% |
TPSC | 30.80% | $182.13M | 0.52% |
VIOV | 30.73% | $1.22B | 0.1% |
SLYV | 30.69% | $3.74B | 0.15% |
IJS | 30.67% | $6.41B | 0.18% |
VIOO | 30.51% | $2.75B | 0.07% |
EFAA | 30.46% | $100.03M | 0% |